Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Due to its shorter duration of action, liraglutide requires daily dosing to maintain effective levels in the system
Clinical studies demonstrate onset of subjective arousal within 6090 minutes at therapeutic doses, with effects lasting 68 hours
Technical Specifications: - Molecular Weight: ~4500 g/mol - Receptor Binding (EC50): GCGR 5.79nM, GIPR 0.0643nM, GLP-1R 0.775nM - Half-life: ~6 days (research data) - Appearance: White lyophilized powder - Storage: -20C Research Background: The peptide adopts a single continuous helical conformation, enabling the N-terminal segment to engage the receptor transmembrane domain while the C-terminal segment interacts with extracellular regions
Collectively, our in vivo and in vitro findings are consistent with TMAO aggravating kidney fibrosis due to ERK1/2 hyperactivation synergistically, probably with activation of the TGF-1-mediated SMAD3 pathway causing a secondary hit in our disease model
US$ 26.16
US$ 22.37
US$ 22.45
US$ 25.70
US$ 25.48
US$ 23.15
US$ 20.63
US$ 25.52
US$ 22.70
US$ 22.08
